Published in Virology on October 01, 1968
Comparison of 17 genome types of adenovirus type 3 identified among strains recovered from six continents. J Clin Microbiol (1988) 1.45
Demonstration of three different subtypes of adenovirus type 7 by DNA restriction site mapping. Infect Immun (1978) 1.38
Immunological and other biological characteristics of pentons of human adenoviruses. J Virol (1969) 1.26
Immunological relationships between hexons of certain human adenoviruses. J Virol (1969) 1.04
Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virus. Infect Immun (1980) 0.95
Capsid mosaics of intermediate strains of human adenoviruses. J Virol (1969) 0.85
Soluble components of adenovirus type 8. J Virol (1970) 0.75
Two distinct subtypes of human respiratory syncytial virus. J Gen Virol (1985) 5.19
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J Gen Virol (1976) 2.78
Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis (1975) 2.54
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res (1985) 2.37
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
The structural and functional diversity of Adenovirus capsid components. J Gen Virol (1969) 2.14
Structural polypeptides of measles virus. J Gen Virol (1978) 2.11
Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1973) 2.10
Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun (1972) 2.08
Adsorption and penetration of enveloped and naked vaccinia virus particles. J Virol (1978) 2.06
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus. Virology (1983) 1.85
Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun (1972) 1.82
Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol (1986) 1.81
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol (1987) 1.73
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol (1976) 1.66
Chromosome damage associated with the measles virus in vitro. Hereditas (1965) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis (1988) 1.58
Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.55
Morphogenesis of respiratory syncytial virus in a green monkey kidney cell line (Vero). J Virol (1970) 1.53
Structural components of measles virus. Microbios (1972) 1.51
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells. Arch Virol (1982) 1.50
Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol (1988) 1.50
Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun (1974) 1.48
Structural differences between subtype A and B strains of respiratory syncytial virus. J Gen Virol (1986) 1.45
Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol (1974) 1.44
Paramyxovirus SV5 and multiple sclerosis. Nature (1989) 1.43
A carrier cell line of measles virus in Lu 106 cells. Arch Gesamte Virusforsch (1967) 1.41
Immunological relationships between homologous structural polypeptides of measles and canine distemper virus. J Gen Virol (1980) 1.40
Immunologic properties of purified Sendai virus glycoproteins. J Immunol (1977) 1.39
The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology (1971) 1.38
The relationship between the soluble antigens and the virion of adenovirus type 3. I. Morphological characteristics. Virology (1966) 1.36
Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol (1986) 1.33
Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol (1987) 1.31
Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology. Infect Immun (1978) 1.28
Respiratory syncytial virus: heterogeneity of subgroup B strains. J Gen Virol (1988) 1.27
Viral antibodies in multiple sclerosis. Prog Med Virol (1978) 1.27
Immunological and other biological characteristics of pentons of human adenoviruses. J Virol (1969) 1.26
Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology (1993) 1.26
Characterization of epitopes on the measles virus hemagglutinin. Virology (1986) 1.25
Immunoglobulins and measles antibodies in optic neuritis. N Engl J Med (1973) 1.22
A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization. J Virol (1990) 1.21
Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol (1982) 1.19
Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol (1994) 1.18
Antibodies against three different structural components of measles virus in patients with multiple sclerosis, their siblings and matched controls. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.17
Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol (1980) 1.17
The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J Gen Virol (1986) 1.16
Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses (1991) 1.16
Separation and characterization of soluble adenovirus type 9 components. J Virol (1967) 1.16
Antibodies against measles virus polypeptides in different disease conditions. Infect Immun (1981) 1.16
Purification, morphology and antigenic characterization of measles virus envelope components. J Gen Virol (1984) 1.16
Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res (1990) 1.16
Ultrastructure of soluble antigens and the virion of adenovirus type 4. Arch Gesamte Virusforsch (1967) 1.15
Complete nucleotide sequence of the hemagglutinin-neuraminidase (HN) mRNA of mumps virus and comparison of paramyxovirus HN proteins. Virus Res (1989) 1.15
Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis. J Virol (1985) 1.15
Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses. Neuropathol Appl Neurobiol (1987) 1.14
Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein. J Med Virol (1987) 1.13
Biological significance of structural adenovirus components. Curr Top Microbiol Immunol (1968) 1.12
The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen. Virology (1967) 1.12
Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein. J Gen Virol (1995) 1.12
IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis. Scand J Immunol (1977) 1.11
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology (1993) 1.11
The relationship between the soluble antigens and the virion of adenovirus type 3. IV. Immunological complexity of soluble components. Virology (1969) 1.10
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. Immunology (1991) 1.09
Mumps meningitis: specific and non-specific antibody responses in the central nervous system. Acta Neurol Scand (1982) 1.09
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A (1991) 1.08
The correlation between the chromosome pulverization effect and other biological activities of measles virus preparations. Exp Cell Res (1966) 1.06
The relationship between the soluble antigens and the virion of adenovirus type 3. II. Identification and characterization of an incomplete hemagglutinin. Virology (1966) 1.06
Isolation of incomplete adenovirus 16 particles containing viral and host cell DNA. Virology (1977) 1.06
Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper. Arch Virol (1984) 1.05
Immunological relationships between hexons of certain human adenoviruses. J Virol (1969) 1.04
Biological phenotype of HIV type 2 isolates correlates with V3 genotype. AIDS Res Hum Retroviruses (1996) 1.04
mRNA sequence and deduced amino acid sequence of the mumps virus small hydrophobic protein gene. J Virol (1989) 1.04
Single radial immunodiffusion test for detecting antibodies against surface antigens of intracellular and extracellular vaccinia virus. J Gen Virol (1977) 1.04
Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus. J Acquir Immune Defic Syndr (1991) 1.04
Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). J Gen Virol (1987) 1.04
Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin. Acta Paediatr Scand (1965) 1.03
Fluctuations and distribution of measles virus antigens in chronically infected cells. Nature (1974) 1.02
Demonstration of electrophoretically restricted virus-specific antibodies in serum and cerebrospinal fluid by imprint electroimmunofixation. Scand J Immunol (1978) 1.02
Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol (1985) 1.02
Preparation and characterization of monoclonal antibodies directed against four structural components of canine distemper virus. J Gen Virol (1985) 1.02
Actin filaments in paramyxovirus-infected human fibroblasts studied by indirect immunofluorescence. Arch Virol (1978) 1.02
Protection against canine distemper virus in dogs after immunization with isolated fusion protein. J Virol (1986) 1.01
Fiber-associated incomplete and complete hemagglutinins of adenovirus type 6. Arch Gesamte Virusforsch (1969) 1.01
A single-season epidemic with respiratory syncytial virus subgroup B2 during 10 epidemic years, 1978 to 1988. J Clin Microbiol (1991) 1.01
Production of antibodies against measles virions by use of the mouse hybridoma technique. Arch Virol (1981) 1.01
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm). J Acquir Immune Defic Syndr (1989) 1.01
Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol (1987) 1.01
Three monoclonal antibodies against measles virus F protein cross-react with cellular stress proteins. J Virol (1984) 1.00
Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus. Arch Virol (1985) 0.99